Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:49 PM
Ignite Modification Date:
2025-12-24 @ 4:49 PM
NCT ID:
NCT00216450
Eligibility Criteria:
Inclusion Criteria:
* Patients diagnosed with Helicobacter pylori (H. pylori) infection
* patients over 45 years of age must have an endoscopic examination of the digestive system
* patients must have positive result of urea breath test (UBT) for H. pylori
* patients being treated with rabeprazole in combination with clarithromycin and amoxycillin to eradicate H. pylori.
Exclusion Criteria:
* Known hypersensitivity to rabeprazole, clarithromycin, or amoxycillin
* evidence from endoscopic examination of gastrointestinal hemorrhage or stomach cancer, or had previous stomach surgery
* use of aspirin, non-steroidal anti-inflammatory drugs (NSAIDs), antibiotics, bismuth, or proton pump inhibitors during the last 4 weeks prior to study initiation
* history of successful treatment to eradicate H.pylori infection
* females who are pregnant or nursing
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT00216450
Study Brief:
Protocol Section:
NCT00216450